ABSTRACT
The efficient syntheses of the ABCD ring system of the originally proposed structure of azaspiracid-1 and the ABCDE ring system of the revised structure of azaspiracid-1 containing the correct stereochemistry at C(6), C(10), C(13), C(14), C(16), C(17), C(19), C(21), C(22), C(24) and C(25) have been achieved.
Subject(s)
Marine Toxins/chemical synthesis , Spiro Compounds/chemical synthesis , Magnetic Resonance Spectroscopy , Marine Toxins/chemistry , Molecular Structure , Spiro Compounds/chemistryABSTRACT
The resistance of Mycobacterium tuberculosis to isoniazid (INH) is largely linked to suppression of a catalase-peroxidase enzyme (KatG) that activates INH. In the absence of KatG, antioxidant protection is provided by enhanced expression of the peroxiredoxin AhpC, which is itself reduced by AhpD, a protein with low alkylhydroperoxidase activity of its own. Inhibition of AhpD might therefore impair the antioxidant protection afforded by AhpC and make KatG-negative strains more sensitive to oxidative stress. We report here that the 3(E),17-dioxime of testosterone is a potent competitive AhpD inhibitor, with a K(i) of 50 +/- 2 nM. The inhibitor is stereospecific, in that the 3(E) but not 3(Z) isomer is active. Computational studies provide support for a proposed AhpD substrate binding site. However, the inhibitor does not completely suppress the in vitro activity of AhpC/AhpD, because a low titer of AhpD suffices to maintain AhpC activity. This finding, and the low solubility of the inhibitor, explains its inability to suppress the growth of INH-resistant M. tuberculosis in infected mouse lungs.
Subject(s)
Antitubercular Agents/pharmacology , Bacterial Proteins , Mycobacterium tuberculosis/drug effects , Oxidative Stress/drug effects , Peroxidases/analysis , Peroxidases/genetics , Peroxidases/pharmacology , Animals , Colony Count, Microbial , Female , Hydrogen Peroxide/pharmacology , Kinetics , Mice , Mice, Inbred C57BL , Microbial Sensitivity Tests , Peroxidases/metabolism , Peroxiredoxins , Sterols/metabolismABSTRACT
Alpha-galactosylceramides are potent stimulators of human T cells. Stimulation occurs through binding of the glycolipids by CD1d, presentation to T cells, and formation of a CD1d-glycolipid-T cell receptor complex. To facilitate the elucidation of the structural features of glycolipids necessary for T cell stimulation, alpha-galactosylceramides have been prepared with small molecules appended at the C6 position of the sugar. The appended molecules do not significantly influence the abilities of the glycolipids to stimulate T cells. [reaction: see text]
